Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

BioA2Z
Profile last edited on: 8/5/16      CAGE: 6SEW6      UEI:

Business Identifier: A novel technology platform regulating membrane proteins for personalized drug screening.
Year Founded
2012
First Award
2013
Latest Award
2013
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1378 19th Avenue
San Francisco, CA 94122
   (415) 963-1514
   info@bioa2z.com
   www.bioa2z.com
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

BioA2Z provides a solution for loss of function assays, target validation, functional genomics, drug discovery, and drug development via a novel technology platform regulating membrane proteins for personalized drug screening.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$149,893
Phase II Dollars
$0
Total Awarded
$149,893

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2013 1 NSF $149,893
Project Title: Innovative drug development kit platform to advance cancer therapy

Key People / Management

  Marcela Karpuj -- Founder and CEO

Company News

There are no news available.